Several reports have suggested that cancer cells expressing EMT-associated markers affect immune cells with anti-tumor functions, such as cytotoxic CD8+ T-cells, and immunosuppressive regulatory cells, such as Treg cells, and thus contribute to the generation of an immunosuppressive TME [71,72]. The gene discussed is CD8A; the disease is neoplasm.